Stan Lipkowitz

3.8k citations
29 papers · 3.0k · 2 hit papers · h-index 23

Impact in

  • Immunology top 2%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
  • Oncology top 2%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research

Papers in

    • Ubiquitin and proteasome pathways 6
    • Cell death mechanisms and regulation 6
    • Glycosylation and Glycoproteins Research 2
    • Protein Degradation and Inhibitors 2
    • Cancer Immunotherapy and Biomarkers 3

Stan Lipkowitz

29 papers receiving 3.0k citations

Stan Lipkowitz's Hit Papers

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options 2022 · 159 citations
1590+8+17Years since publication100200300400500

Peers

Stan Lipkowitz
Comparison fields: 5 of 97
  • Immunology 938
  • Oncology 1.1k
  • Cancer Research 375
  • Molecular Biology 1.8k
  • Immunology and Allergy 79
Replace María J. Pajares with:
María J. Pajares Spain
Sudarshan Anand United States
Seth A. Ettenberg United States
Viia Valge-Archer United Kingdom
Marion Dorsch United States
Ralf Brandt United States
Su Yin Lim Australia
Mary L. Bath Australia
Veronica Steri United States
Sarajane Ross United States
Stan Lipkowitz relative to María J. Pajares Spain María J. Pajares's profile →
Citations per field
00.5×1.5×1.9×
María J. Pajares · 1×
Citations per year

Countries citing papers authored by Stan Lipkowitz

Since Specialization
Citations

This map shows the geographic impact of Stan Lipkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan Lipkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan Lipkowitz more than expected).

Fields of papers citing papers by Stan Lipkowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stan Lipkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan Lipkowitz. The network helps show where Stan Lipkowitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Stan Lipkowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stan Lipkowitz Line = papers co-authored together Stan Lipkowitz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
Hit paper breakdown →
2000556
2
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
2001302
3
Fas expression and function in normal and malignant breast cell lines.
1996214
4
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options
Hit paper breakdown →
2022159
5 2004152
6 2004149
7 2003144
8 2001136
9 2002126
10 2001125
11
The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.
1996115
12 1999103
13 200498
14 199996
15 200490
16 200087
17 200471
18 199769
19 200567
20 200245

About Stan Lipkowitz

Stan Lipkowitz is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Genetics, having authored 29 papers that have together received 3.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Cell death mechanisms and regulation (6 papers), NF-κB Signaling Pathways (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Genomics and Diagnostics (2 papers), BRCA gene mutations in cancer (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Immunology (938 citations), Oncology (1.1k citations), Cancer Research (375 citations), Molecular Biology (1.8k citations) and Immunology and Allergy (79 citations). Stan Lipkowitz has collaborated with scholars based in United States, Canada and Chile. Frequent co-authors include Seth A. Ettenberg, Marion M. Nau, Maccon Keane, Mauricio Cuello, Josef Penninger, E K Russell, Yang Li, Jae Young So, Joyce E. Ohm and Amy S. Clark. Their work appears in journals such as Journal of Clinical Oncology, Oncogene, Journal of Biological Chemistry, Cancer Research and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact